Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
14.99
+0.04 (0.27%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Avalo Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $60 | Buy | Maintains | $60 | +300.27% | Oct 1, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $50 → $48 | Buy | Reiterates | $50 → $48 | +220.21% | Aug 7, 2026 |
| BTIG | BTIG | Buy Maintains $58 | Buy | Maintains | $58 | +286.92% | Aug 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $35 | Buy | Reiterates | $35 | +133.49% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 → $30 | Buy | Reiterates | $35 → $30 | +100.13% | Aug 7, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $38 | Buy | Initiates | $38 | +153.50% | Jul 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 11, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $36 → $39 | Buy | Maintains | $36 → $39 | +160.17% | May 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.